Table 5 Baseline Patient’s Characteristics Stratified by All-cause mortality at 30 days

 Age, years

74 (69–80)

77 (67–84)

0.683^a

 Male sex

21 (70.0)

37 (51.4)

0.124^c

 Body mass index

21.4 (17.0–24.2)

21.7 (19.2–25.5)

0.352^a

 Creatinine clearance, mL/min

21.3 (12.7–29.4)

20.6 (12.4–42.6)

0.523^a

 Renal replacement therapy

20 (66.7)

35 (48.6)

0.147^b

 Malignancy

8 (26.7)

14 (19.4)

0.437^c

 Serum albumin, mg/dL

2.15 (1.90–2.50)

2.45 (2.08–2.73)

0.093^a

 SOFA score

15 (12–17)

10 (8–12)

< 0.001^a

 JAAM-DIC score

6 (5–7)

6 (5–7)

0.448^a

 SIRS criteria

3 (2–4)

3 (2–4)

0.832^a

 Intra-abdominal infection

4 (13.3)

21 (29.2)

0.129^c

 Pneumonia

14 (46.7)

9 (12.5)

< 0.001^c

 Urinary tract infection

2 (6.7)

15 (20.8)

0.142^c

 Cholangitis/Cholecystitis

0 (0.0)

9 (12.5)

0.055^c

 Blood stream infection

3 (10.0)

4 (5.6)

0.417^c

 Infectious enteritis

0 (0.0)

2 (2.8)

1.000^c

 Necrotizing fasciitis/Gas gangrene

0 (0.0)

2 (2.8)

1.000^c

 Osteomyelitis

1 (3.3)

1 (1.4)

0.504^c

 Iliopsoas muscle abscess/Retroperitoneal abscess

0 (0.0)

2 (2.8)

1.000^c

 Unknown

5 (16.7)

4 (5.6)

0.119^c

 Dose reduction of TM

14 (46.7)

16 (22.2)

0.026^b

 Antithrombin III

26 (86.7)

52 (72.2)

0.133^c

 Heparin

1 (3.3)

2 (2.8)

1.000^c

 Fresh frozen plasma

11 (36.7)

18 (25.0)

0.342^b

 Platelet Concentrate

12 (40.0)

25 (34.7)

0.780^b

 PMX-DHP

8 (26.7)

40 (55.6)

0.009^c